78 related articles for article (PubMed ID: 2210607)
1. Angioscintigraphic assessment of hemodynamic effects of penbutolol in cirrhotics with portal hypertension. A double-blind, randomized, controlled study.
Santambrogio R; Bruno S; Opocher E; Galeotti F; Zatta G; Grugni M; Macri M; Pisani A; Tarolo G; Spina G
Hepatogastroenterology; 1990 Aug; 37(4):398-402. PubMed ID: 2210607
[TBL] [Abstract][Full Text] [Related]
2. [The noninvasive assessment of the effects of penbutolol on liver hemodynamics in cirrhotic patients using angioscintigraphy. A randomized controlled double-blind study].
Santambrogio R; Opocher E; Bruno S; Chiesa A; Gagliano G; Rossi S; Grugni MC; Zatta G; Bestetti A; Vignati L
Recenti Prog Med; 1990 Nov; 81(11):705-9. PubMed ID: 1962892
[TBL] [Abstract][Full Text] [Related]
3. Angioscintigraphic assessment of arterial and portal liver blood flow: comparison with splanchnic angiography.
Zatta G; Santambrogio R; Boccolari S; Mana O; Gattoni F; Baldini U; Galeotti F; Opocher E; Spina GP; Tarolo GL
Nuklearmedizin; 1987 Apr; 26(2):83-6. PubMed ID: 3588322
[TBL] [Abstract][Full Text] [Related]
4. Effects of Sapropterin on Portal and Systemic Hemodynamics in Patients With Cirrhosis and Portal Hypertension: A Bicentric Double-Blind Placebo-Controlled Study.
Reverter E; Mesonero F; Seijo S; Martínez J; Abraldes JG; Peñas B; Berzigotti A; Deulofeu R; Bosch J; Albillos A; García-Pagán JC
Am J Gastroenterol; 2015 Jul; 110(7):985-92. PubMed ID: 26077176
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
Abraldes JG; Albillos A; Bañares R; Turnes J; González R; García-Pagán JC; Bosch J
Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
[TBL] [Abstract][Full Text] [Related]
6. Estimation of the relative liver perfusion using two methods of radionuclide angiography in the patients with hemodynamic disorders in the portal system.
Artiko VM; Sobić-Saranović DP; Pavlović SV; Perisić-Savić MS; Stojković MV; Radoman IB; Knezević SJ; Vlajković MZ; Obradović VB
Acta Chir Iugosl; 2008; 55(1):11-6. PubMed ID: 18510056
[TBL] [Abstract][Full Text] [Related]
7. Short term effects of valsartan on portal blood flow in cirrhotic patients.
Yalniz M; Demir A; Arslan A; Cihangiroğlu M
Turk J Gastroenterol; 2003 Mar; 14(1):18-25. PubMed ID: 14593533
[TBL] [Abstract][Full Text] [Related]
8. NCX-1000, a nitric oxide-releasing derivative of UDCA, does not decrease portal pressure in patients with cirrhosis: results of a randomized, double-blind, dose-escalating study.
Berzigotti A; Bellot P; De Gottardi A; Garcia-Pagan JC; Gagnon C; Spénard J; Bosch J
Am J Gastroenterol; 2010 May; 105(5):1094-101. PubMed ID: 19920806
[TBL] [Abstract][Full Text] [Related]
9. Use of a nonselective beta-blocker, nadolol, in the treatment of portal hypertension in cirrhotics.
Gatta A; Sacerdoti D; Merkel C; Rossoni R; Finucci G; Bolognesi M; Zuin R
Int J Clin Pharmacol Res; 1985; 5(6):413-8. PubMed ID: 4093219
[TBL] [Abstract][Full Text] [Related]
10. [Value of hepatic angioscintigraphy combined to pulsed Echo-Doppler: application to the study of portal hypertension of cirrhotic patients. Apropos of 148 cases].
Bouvard G; Bouvard N; Dao T; el Fadel S; Fernandez Y
Ann Radiol (Paris); 1991; 34(6-7):362-8. PubMed ID: 1822659
[TBL] [Abstract][Full Text] [Related]
11. Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension.
Hernández-Guerra M; García-Pagán JC; Turnes J; Bellot P; Deulofeu R; Abraldes JG; Bosch J
Hepatology; 2006 Mar; 43(3):485-91. PubMed ID: 16496307
[TBL] [Abstract][Full Text] [Related]
12. The effects of carvedilol a nonselective beta-blocker on portal hemodynamics in cirrhosis.
Fierbinteanu-Braticevici C; Udeanu M; Dragomir P; Andronescu D
Rom J Intern Med; 2003; 41(3):247-54. PubMed ID: 15526508
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of action of isosorbide-5-mononitrate in reducing portal pressure in cirrhotic patients with cirrhosis and portal hypertension.
Jenkins SA; Shields R
J Gastroenterol Hepatol; 1991; 6(1):91-3. PubMed ID: 1883984
[No Abstract] [Full Text] [Related]
14. Effects of the adjunctive probiotic VSL#3 on portal haemodynamics in patients with cirrhosis and large varices: a randomized trial.
Gupta N; Kumar A; Sharma P; Garg V; Sharma BC; Sarin SK
Liver Int; 2013 Sep; 33(8):1148-57. PubMed ID: 23601333
[TBL] [Abstract][Full Text] [Related]
15. Influence of long-term injection sclerotherapy on portal venous component of total liver perfusion measured by hepatosplenic radionuclide angiography.
Sauerbruch T; Moser E
Hepatogastroenterology; 1986 Feb; 33(1):17-9. PubMed ID: 3957225
[TBL] [Abstract][Full Text] [Related]
16. Radionuclide hepatic perfusion index and ultrasonography: assessment of portal hypertension in clinical practice.
Seidlová V; Hobza J; Pumprla J; Charouzek J
Acta Univ Palacki Olomuc Fac Med; 1989; 122():213-21. PubMed ID: 2530818
[TBL] [Abstract][Full Text] [Related]
17. Three months of simvastatin therapy vs. placebo for severe portal hypertension in cirrhosis: A randomized controlled trial.
Pollo-Flores P; Soldan M; Santos UC; Kunz DG; Mattos DE; da Silva AC; Marchiori RC; Rezende GF
Dig Liver Dis; 2015 Nov; 47(11):957-63. PubMed ID: 26321186
[TBL] [Abstract][Full Text] [Related]
18. [Effect of ACE inhibitor (ednit) on portal hemodynamics in patients with hepatic cirrhosis].
Postnikova TN; Larina EA; Berdnikov SV; Serov NA
Klin Med (Mosk); 1999; 77(12):46-7. PubMed ID: 10684217
[No Abstract] [Full Text] [Related]
19. [Adrenergic beta blockade in liver cirrhosis with portal hypertension? Doppler ultrasound measurement of the short-term effect of propranolol on the portal system].
Wruck U; Wermke W
Z Arztl Fortbild (Jena); 1992 Apr; 86(7-8):371-5. PubMed ID: 1615718
[No Abstract] [Full Text] [Related]
20. A 3-month course of long-acting repeatable octreotide (sandostatin LAR) improves portal hypertension in patients with cirrhosis: a randomized controlled study.
Spahr L; Giostra E; Frossard JL; Morard I; Mentha G; Hadengue A
Am J Gastroenterol; 2007 Jul; 102(7):1397-405. PubMed ID: 17488248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
